DK4009942T3 - Forbindelse til kombinationsbehandling - Google Patents

Forbindelse til kombinationsbehandling Download PDF

Info

Publication number
DK4009942T3
DK4009942T3 DK20751149.4T DK20751149T DK4009942T3 DK 4009942 T3 DK4009942 T3 DK 4009942T3 DK 20751149 T DK20751149 T DK 20751149T DK 4009942 T3 DK4009942 T3 DK 4009942T3
Authority
DK
Denmark
Prior art keywords
connection
combination treatment
treatment
combination
Prior art date
Application number
DK20751149.4T
Other languages
English (en)
Inventor
Ulf Simonsen
Simon Comerma-Steffensen
Dan Peters
Original Assignee
Initiator Pharma As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Initiator Pharma As filed Critical Initiator Pharma As
Application granted granted Critical
Publication of DK4009942T3 publication Critical patent/DK4009942T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
    • C07D451/04—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof with hetero atoms directly attached in position 3 of the 8-azabicyclo [3.2.1] octane or in position 7 of the 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring system
    • C07D451/06—Oxygen atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Gynecology & Obstetrics (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DK20751149.4T 2019-08-06 2020-08-06 Forbindelse til kombinationsbehandling DK4009942T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP19190224 2019-08-06
PCT/EP2020/072092 WO2021023805A1 (en) 2019-08-06 2020-08-06 Compound for combination treatment

Publications (1)

Publication Number Publication Date
DK4009942T3 true DK4009942T3 (da) 2023-10-23

Family

ID=67551141

Family Applications (1)

Application Number Title Priority Date Filing Date
DK20751149.4T DK4009942T3 (da) 2019-08-06 2020-08-06 Forbindelse til kombinationsbehandling

Country Status (16)

Country Link
US (1) US20220288052A1 (da)
EP (2) EP4009942B1 (da)
JP (1) JP7605825B2 (da)
KR (1) KR20220054593A (da)
CN (1) CN114430679A (da)
AU (1) AU2020326244B2 (da)
BR (1) BR112022002169A2 (da)
CA (1) CA3146837A1 (da)
DK (1) DK4009942T3 (da)
ES (1) ES2962648T3 (da)
FI (1) FI4009942T3 (da)
IL (1) IL290319B2 (da)
MX (1) MX2022000356A (da)
PL (1) PL4009942T3 (da)
WO (1) WO2021023805A1 (da)
ZA (1) ZA202200723B (da)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20260216166A1 (en) * 2023-01-03 2026-07-30 Initiator Pharma A/S Compound for treatment of erectile dysfunction
WO2025051846A1 (en) 2023-09-05 2025-03-13 Initiator Pharma A/S Compound for treatment of female sexual dysfunction

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003240434A1 (en) * 2002-06-20 2004-01-06 H. Lundbeck A/S Combination therapy wherein a serotinin reuptake inhibitor is used
RU2354377C2 (ru) * 2003-07-11 2009-05-10 Берингер Ингельхайм Ветмедика Гмбх Способ лечения или предупреждения заболеваний центральной нервной системы с использованием соединений, обладающих селективностью в отношении альфа-3-субъединицы бензодиазепинового рецептора
US7696350B2 (en) * 2004-09-30 2010-04-13 Neurosearch A/S Chromen-2-one derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
JP2010513392A (ja) 2006-12-20 2010-04-30 ノイロサーチ アクティーゼルスカブ 新規クロメン−２−オン誘導体及びモノアミン神経伝達物質再取り込み阻害薬としてのそれらの使用
WO2010020651A1 (en) 2008-08-21 2010-02-25 Neurosearch A/S Treatment of anxiety disorders
US20130040985A1 (en) * 2010-01-29 2013-02-14 Neurosearch A/S Chromen-2-one derivatives and their use as monoamine neurotransmitter re-uptake inhibitors

Also Published As

Publication number Publication date
IL290319B2 (en) 2023-06-01
FI4009942T3 (fi) 2023-09-26
EP4009942B1 (en) 2023-08-09
US20220288052A1 (en) 2022-09-15
JP2022544463A (ja) 2022-10-19
EP4241839A3 (en) 2023-11-15
EP4009942A1 (en) 2022-06-15
BR112022002169A2 (pt) 2022-06-07
ES2962648T3 (es) 2024-03-20
WO2021023805A1 (en) 2021-02-11
AU2020326244A1 (en) 2022-03-17
MX2022000356A (es) 2022-05-11
ZA202200723B (en) 2022-08-31
CN114430679A (zh) 2022-05-03
IL290319A (en) 2022-04-01
CA3146837A1 (en) 2021-02-11
EP4241839A2 (en) 2023-09-13
AU2020326244B2 (en) 2025-06-05
PL4009942T3 (pl) 2024-04-08
JP7605825B2 (ja) 2024-12-24
KR20220054593A (ko) 2022-05-03

Similar Documents

Publication Publication Date Title
IL281348A (en) Combination therapies
IL281344A (en) Combination therapies
IL285771A (en) Therapeutic uses of relacorilant, a heteroaryl-ketone fused azadecalin glucocorticoid receptor modulator
DK3360508T3 (da) Hjælpeanordning til dental behandling
DK3601553T3 (da) Alfa-amylase-kombinationsvarianter
DK3612624T3 (da) Genterapi
EP3686818C0 (en) WATER TREATMENT SYSTEM
DK3362066T3 (da) Kombinationsterapi til behandling af maligniteter
DK3577219T3 (da) Alfa-amylase-varianter
EP3603109A4 (en) VIBRO-ACOUSTIC TRANSDUCER
IL282330A (en) Therapeutic compounds
EP3735463A4 (en) Cytotoxicity-inducing therapeutic agent
HUE050944T2 (hu) Kezelési eljárás tradipitant alkalmazásával
IL256206A (en) Mct4 inhibitors for treating disease
EP3860585A4 (en) Therapeutic compositions
DK3452475T3 (da) Tetrahydropyridodiazepinforbindelser til at behandle smerte og smerterelaterede tilstande
IL292502A (en) Therapeutic methods using vadadustat
EP3597225A4 (en) TREATMENT PROCESS
PL3755363T3 (pl) Warianty plantarycyny nc8alfabeta
EP3606879A4 (en) WATER TREATMENT SYSTEM
IL280968A (en) Combination therapy
DK3724336T3 (da) Forbedret forbindelse til behandling af hjerteinsufficiens
IL281839A (en) Treatment methods
IL281792A (en) Treatment methods
EP3838145A4 (en) OXYMETER